Evidence map›Paper›PMID 35091964›Full record

Observational studyJournal of assisted reproduction and genetics2022

Probability of high-risk genetic matching with oocyte and semen donors: complete gene analysis or genotyping test?

Marta Molina Romero, Alberto Yoldi Chaure, Miguel Gañán Parra, Purificación Navas Bastida, José Luis Del Pico Sánchez, Ángel Vaquero Argüelles, Paloma de la Fuente Vaquero, Juan Pablo Ramírez López, José Antonio Castilla Alcalá

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Journal of assisted reproduction and genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Marta Molina RomeroCEIFER Biobanco - NextClinics, Calle Maestro Bretón, 1, 18004, Granada, Spain. molinaromeromarta@gmail.com.ORCID http://orcid.org/0000-0002-4131-4597
Alberto Yoldi ChaureCEIFER Biobanco - NextClinics, Calle Maestro Bretón, 1, 18004, Granada, Spain.
Miguel Gañán ParraCEIFER Biobanco - NextClinics, Sevilla, Spain.
Purificación Navas BastidaCEIFER Biobanco - NextClinics, Córdoba, Spain.
José Luis Del Pico SánchezCEIFER Biobanco - NextClinics, Calle Maestro Bretón, 1, 18004, Granada, Spain.
Ángel Vaquero ArgüellesCEIFER Biobanco - NextClinics, Calle Maestro Bretón, 1, 18004, Granada, Spain.
Paloma de la Fuente VaqueroCEIFER Biobanco - NextClinics, Sevilla, Spain.
Juan Pablo Ramírez LópezCEIFER Biobanco - NextClinics, Calle Maestro Bretón, 1, 18004, Granada, Spain.
José Antonio Castilla AlcaláCEIFER Biobanco - NextClinics, Calle Maestro Bretón, 1, 18004, Granada, Spain.
BioClinica (United States) · USInstituto de Investigación Biosanitaria de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo estimate the probability of high-risk genetic matching when assisted reproductive techniques (ART) are applied with double gamete donation, following an NGS carrier test based on a complete study of the genes concerned. We then determine the results that would have been obtained if the genotyping tests most widely used in Spanish gamete banks had been applied.

methodsIn this descriptive observational study, 1818 gamete donors were characterised by NGS. The pathogenic variants detected were analysed to estimate the probability of high-risk genetic matching and to determine the results that would have been obtained if the three most commonly used genotyping tests in ART had been applied.

resultsThe probability of high-risk genetic matching with gamete donation, screened by NGS and complete gene analysis, was 5.5%, versus the 0.6-2.7% that would have been obtained with the genotyping test. A total of 1741 variants were detected, including 607 different variants, of which only 22.6% would have been detected by all three genotyping tests considered and 44.7% of which would not have been detected by any of these tests.

conclusionOur study highlights the considerable heterogeneity of the genotyping tests, which present significant differences in their ability to detect pathogenic variants. The complete study of the genes by NGS considerably reduces reproductive risks when genetic matching is performed with gamete donors. Accordingly, we recommend that carrier screening in gamete donors be carried out using NGS and a complete study with nontargeted analysis of the variants of the screened genes.

Indexed as

Genetic TestingTissue DonorsGenotypeHumansOocyte DonationOocytesProbabilityCarrier screeningGamete donorsGenetic matchingGenotyping testNext-generation sequencingRecessive disease

Identifiers

PMID35091964
PMCPMC8956772
OpenAlexW4210555304

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.